These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 10612798)

  • 81. Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations.
    Serra E; Rosenbaum T; Winner U; Aledo R; Ars E; Estivill X; Lenard HG; Lázaro C
    Hum Mol Genet; 2000 Dec; 9(20):3055-64. PubMed ID: 11115850
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Surgery for atypical plexiform neurofibromas of the trunk in NF1 with high standardised uptake value (SUV) in positron-emission tomography (PET) expressing podoplanin: a long-term follow-up.
    Friedrich RE; Gawad K; Derlin T; Zustin J; Hagel C
    Anticancer Res; 2012 Oct; 32(10):4547-51. PubMed ID: 23060584
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Modeling tumors of the peripheral nervous system associated with Neurofibromatosis type 1: Reprogramming plexiform neurofibroma cells.
    Mazuelas H; Carrió M; Serra E
    Stem Cell Res; 2020 Dec; 49():102068. PubMed ID: 33160273
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Mouse models of tumor development in neurofibromatosis type 1.
    Cichowski K; Shih TS; Schmitt E; Santiago S; Reilly K; McLaughlin ME; Bronson RT; Jacks T
    Science; 1999 Dec; 286(5447):2172-6. PubMed ID: 10591652
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Angiogenic and invasive properties of neurofibroma Schwann cells.
    Sheela S; Riccardi VM; Ratner N
    J Cell Biol; 1990 Aug; 111(2):645-53. PubMed ID: 1696266
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Reprogramming Captures the Genetic and Tumorigenic Properties of Neurofibromatosis Type 1 Plexiform Neurofibromas.
    Carrió M; Mazuelas H; Richaud-Patin Y; Gel B; Terribas E; Rosas I; Jimenez-Delgado S; Biayna J; Vendredy L; Blanco I; Castellanos E; Lázaro C; Raya Á; Serra E
    Stem Cell Reports; 2019 Feb; 12(2):411-426. PubMed ID: 30713041
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Tumor suppressor mutations and growth factor signaling in the pathogenesis of NF1-associated peripheral nerve sheath tumors: II. The role of dysregulated growth factor signaling.
    Carroll SL; Stonecypher MS
    J Neuropathol Exp Neurol; 2005 Jan; 64(1):1-9. PubMed ID: 15715079
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Does Schwann cell dedifferentiation originate dermal neurofibromas?
    Iribar H; Jaka A; Ormaechea N; Tuneu A; Izeta A; Gutiérrez-Rivera A
    Exp Dermatol; 2016 Nov; 25(11):901-903. PubMed ID: 27303947
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The Challenge of Cancer Genomics in Rare Nervous System Neoplasms: Malignant Peripheral Nerve Sheath Tumors as a Paradigm for Cross-Species Comparative Oncogenomics.
    Carroll SL
    Am J Pathol; 2016 Mar; 186(3):464-77. PubMed ID: 26740486
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Longitudinal study of neurofibromatosis 1 associated plexiform neurofibromas.
    Tucker T; Friedman JM; Friedrich RE; Wenzel R; Fünsterer C; Mautner VF
    J Med Genet; 2009 Feb; 46(2):81-5. PubMed ID: 18930997
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Schwann-like cells cultured from human dermal neurofibromas. Immunohistological identification and response to Schwann cell mitogens.
    Pleasure D; Kreider B; Sobue G; Ross AH; Koprowski H; Sonnenfeld KH; Rubenstein AE
    Ann N Y Acad Sci; 1986; 486():227-40. PubMed ID: 3032056
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Molecular, genetic, and cellular pathogenesis of neurofibromas and surgical implications.
    Gottfried ON; Viskochil DH; Fults DW; Couldwell WT
    Neurosurgery; 2006 Jan; 58(1):1-16; discussion 1-16. PubMed ID: 16385324
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Hybrid peripheral nerve sheath tumors, including a malignant variant in type 1 neurofibromatosis.
    Kacerovska D; Michal M; Kuroda N; Tanaka A; Sima R; Denisjuk N; Kreuzberg B; Ricarova R; Kazakov DV
    Am J Dermatopathol; 2013 Aug; 35(6):641-9. PubMed ID: 23676318
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Value of S-100 protein in the diagnosis of soft tissue tumors with particular reference to benign and malignant Schwann cell tumors.
    Weiss SW; Langloss JM; Enzinger FM
    Lab Invest; 1983 Sep; 49(3):299-308. PubMed ID: 6310227
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Losses in chromosomes 17, 19, and 22q in neurofibromatosis type 1 and sporadic neurofibromas: a comparative genomic hybridization analysis.
    Koga T; Iwasaki H; Ishiguro M; Matsuzaki A; Kikuchi M
    Cancer Genet Cytogenet; 2002 Jul; 136(2):113-20. PubMed ID: 12237234
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The role of nerve microenvironment for neurofibroma development.
    Liao CP; Pradhan S; Chen Z; Patel AJ; Booker RC; Le LQ
    Oncotarget; 2016 Sep; 7(38):61500-61508. PubMed ID: 27517146
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1-a consensus overview.
    Miettinen MM; Antonescu CR; Fletcher CDM; Kim A; Lazar AJ; Quezado MM; Reilly KM; Stemmer-Rachamimov A; Stewart DR; Viskochil D; Widemann B; Perry A
    Hum Pathol; 2017 Sep; 67():1-10. PubMed ID: 28551330
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Characterization of Schwann cells from normal nerves and from neurofibromas in the bicolour damselfish.
    Schmale MC; Gill KA; Cacal SM; Baribeau SD
    J Neurocytol; 1994 Nov; 23(11):668-81. PubMed ID: 7861183
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Immortalization of human normal and NF1 neurofibroma Schwann cells.
    Li H; Chang LJ; Neubauer DR; Muir DF; Wallace MR
    Lab Invest; 2016 Oct; 96(10):1105-15. PubMed ID: 27617404
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Aberrant expression of tenascin-c and neuronatin in malignant peripheral nerve sheath tumors.
    Dugu L; Hayashida S; Nakahara T; Xie L; Iwashita Y; Liu X; Uchi H; Tateuchi S; Takahara M; Oda Y; Moroi Y; Furue M
    Eur J Dermatol; 2010; 20(5):580-4. PubMed ID: 20610366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.